Spotlight: Moving Towards a More Inclusive Life Sciences Industry

Get access to an ED&I toolkit from MassBio As our CEO, Tilton Little, was one of the 160+ life sciences CEOs that signed MassBio’s CEO Pledge for a More Equitable and Inclusive Life Sciences Industry, Big4Bio will work towards creating a more diverse life sciences industry. MassBio can help your company launch, analyze, and/or strengthen […]

Read More

Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics

LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]

Read More

Spotlight: Sikich — A Formula for Life Science Success

Sikich LLP is a 1000 member business advisory firm that offers technology and accounting services to a broad array of companies. In operation for more than 35 years, about 10 years ago the company started offering its services to life sciences companies, tailored to fit their specific needs. Big4Bio editor Marie Daghlian recently met virtually […]

Read More

Spotlight: Cerevance Raises $45 Million to Advance Therapeutics Against Novel CNS Targets

by Marie Daghlian Cerevance has raised $45 million in a series B financing to continue deploying its platform to identify novel therapeutic targets for central nervous system diseases, and advance a pipeline of therapies for Parkinson’s disease, Alzheimer’s disease, and neuroinflammation. New investors GV, Bill Gates, and Foresite Capital joined previous investors Takeda Ventures, the […]

Read More

Big4Bio:Boston COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More

SPOTLIGHT: Big4Bio:Boston 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the Boston region! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in Boston’s research, pharma, and biotech industries as you look ahead to a fruitful 2020. Compared to 2018, life sciences venture investment fell in Boston and across the United […]

Read More

Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy

Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]

Read More

Spotlight: Catching Up With CO.DON AG CEO, Ralf Jakobs

LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants   Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]

Read More